While these outcomes are impressive, keep in mind that every weight loss journey is unique the amount of weight you can lose on Zepbound or any other GLP-1 depends on a variety of factors, including your starting weight, overall health, lifestyle, and more
reported full-year worldwide revenue of about $65 billion in 2025, with Keytruda (pembrolizumab)/Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) sales amounting to roughly $31.7 billion and continuing to be the companys dominant growth engine, alongside contributions from pulmonary arterial hypertension (PAH) drug Winrevair (sotatercept-csrk), pneumonia vaccine Capvaxive (neumococcal 21-valent conjugate vaccine) and animal health products
Blood test markers to discuss with a clinician Marker A1c Why it matters Shows longer-term glucose control before and during metabolic-pathway stacking
The case for long-term treatment An increasing number of medical professionals view GLP-1 therapy as a long-term or permanent treatment for obesity, similar to how statins are used long-term for cholesterol management or blood pressure medications are used indefinitely for hypertension
There was also a reduction in total glutathione in the skeletal muscle of animals who exercised, compared to the sedentary control animals
This results in more sustainable weight management, with most users finding it easier to maintain healthy eating habits
